Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo

Because most patients with multiple myeloma (MM) develop resistance to current regimens, novel approaches are needed. Genetically modified, replication-competent oncolytic viruses exhibit high tropism for tumor cells regardless of cancer stage and prior treatment. Receptors of oncolytic herpes simpl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghose, Jayeeta, Dona, Ada, Murtadha, Mariam, Gunes, Emine Gulsen, Caserta, Enrico, Yoo, Ji Young, Russell, Luke, Jaime-Ramirez, Alena Cristina, Barwick, Benjamin G., Gupta, Vikas A., Sanchez, James F., Sborov, Douglas W., Rosen, Steven T., Krishnan, Amrita, Boise, Lawrence H., Kaur, Balveen, Hofmeister, Craig C., Pichiorri, Flavia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940704/
https://www.ncbi.nlm.nih.gov/pubmed/33738338
http://dx.doi.org/10.1016/j.omto.2021.02.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940704/
https://www.ncbi.nlm.nih.gov/pubmed/33738338
http://dx.doi.org/10.1016/j.omto.2021.02.009

Ejemplares similares